Izotropic CEO Resigns
Vancouver, British Columbia--(Newsfile Corp. - June 8, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical imaging device company, announces that effective May 31, 2023, Dr. John McGraw has resigned as Chief Executive Officer (CEO) for personal reasons and has stepped down from the Company's Board of Directors. Dr. McGraw will remain an Advisor to the Company and consult on future projects. The Company thanks Dr. McGraw for his service...
2023-06-08 8:00 AM EDT
Mitglieder des technischen und wissenschaftlichen Teams von Izotropic setzen sich für die Kommerzialisierung der Brust-CT-Technologie ein
Vancouver, British Columbia--(Newsfile Corp. - Montag, 27. Februar 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Medizintechnikunternehmen, das die dedizierte Brust-CT-Bildgebungsplattform (Computertomographie) IzoView für eine präzisere Erkennung und Diagnose von Brustkrebs vermarktet, veröffentlicht erstmalig Erklärungen von wichtigen ausgewählten Mitgliedern seiner technischen und wissenschaftlichen Teams, die sich für die...
2023-02-27 5:23 PM EST
Izotropic's Technical & Scientific Team Members Advocate for Commercialization of Breast CT Technology
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, releases statements from select key members of its technical and scientific teams advocating for the commercialization and clinical capabilities of breast CT...
2023-02-23 8:00 AM EST
Izotropic veröffentlicht erstes Video von Izoview
Vancouver, British Columbia--(Newsfile Corp. - Dienstag, 10. Januar 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Medizintechnikunternehmen, das die spezielle Brust-CT-Bildgebungsplattform IzoView (Computertomographie) für eine genauere Brustkrebserkennung und -diagnose vermarktet, freut sich, das erste Video zu veröffentlichen, das die fertige Entwicklung von IzoView zeigt. Das Video ist das erste in einer Reihe von...
2023-01-10 3:44 PM EST
Izotropic Releases First Video of IzoView
Vancouver, British Columbia--(Newsfile Corp. - January 9, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, is pleased to release the first video showcasing the completed engineering of IzoView. This video is the first in a series of presentations, interviews, and...
2023-01-09 8:00 AM EST
Izotropic Reports Board Meeting Results
Vancouver, British Columbia--(Newsfile Corp. - January 4, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, reports the results of the board meeting held December 29, 2022. The Board of Directors is pleased to report the strengthening and refocussing of Izotropic's...
2023-01-04 8:00 AM EST
Izotropic schließt Entwicklung und Konstruktion von IzoView ab, bereitet abschließende Tests vor
Vancouver, British Columbia--(Newsfile Corp. - Montag, 5. Dezember 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Medizintechnikunternehmen, das die spezielle Brust-CT-Bildgebungsplattform IzoView (Computertomographie) für eine genauere Brustkrebserkennung und -diagnose vermarktet, freut sich, anzukündigen, dass es die technische Entwicklung von IzoView endgültig abgeschlossen hat. Der Aufbau von IzoView ist jetzt vollständig und...
2022-12-05 5:38 PM EST
Izotropic Completes IzoView Development and Assembly, Prepares for Final Testing
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers is pleased to announce that it has completed the final engineering of IzoView. IzoView is now fully assembled and being prepared for final software testing and...
2022-12-01 8:00 AM EST
Alexander Tokman Joins Izotropic Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - November 11, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, announces that Advisor Mr. Alexander Tokman has joined the Company's Board of Directors. Strengthening the Board of Directors with strategic and well-connected...
2022-11-11 8:00 AM EST
Izotropic's IzoView Is Weeks Away from Final Engineering & Showcasing to Investment and Scientific Communities
Vancouver, British Columbia--(Newsfile Corp. - October 25, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, announces that the engineering and construction of IzoView is weeks away from completion and subsequent unveiling to existing shareholders, and the investment,...
2022-10-25 8:00 AM EDT
Izotropic Finalizes Engineering and Development Transition to the United States; Establishes Operations in Primary Target Market
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a MedTech company commercializing IzoView, an advanced three-dimensional computed tomography (3D CT) breast imaging platform for the more accurate detection and diagnosis of breast cancer, is pleased to report the Company has successfully relocated IzoView and associated components and completed the transition of all major medical device...
2022-08-11 8:00 AM EDT
Izotropic Engages Clinical Research Organization in Preparation for Clinical Study
Vancouver, British Columbia--(Newsfile Corp. - July 19, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a MedTech company commercializing IzoView, an advanced breast CT (computed tomography) imaging platform for the more accurate detection and diagnosis of breast cancer, announces it has engaged a world-leading clinical research organization (CRO) ICON plc ("ICON") to help prepare for its upcoming clinical study and submission for market...
2022-07-19 8:00 AM EDT
Izotropic Reacts to Supply Chain Disruptions and Updates IzoView Engineering Timelines
Vancouver, British Columbia--(Newsfile Corp. - June 29, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, announces timeline updates for the initial IzoView commercial prototype build. Supply chain issues and unforeseen impacts on engineering work have resulted in an estimated delay of...
2022-06-29 9:00 AM EDT
Izotropic stellt kommerziellen IzoView-Prototyp vor und reicht neue Patente ein
Vancouver, British Columbia--(Newsfile Corp. - Donnerstag, 12. Mai 2022) - Die Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Unternehmen, das seine Brust-CT (Computertomographie)-Bildgebungsplattform IzoView für die genauere Brustkrebserkennung und -diagnose kommerzialisiert, freut sich, das kommerzielle Prototyp-Gerätedesign vorzustellen, das in bevorstehenden klinischen Studien zur Marktzulassung in den USA eingesetzt wird.
2022-05-12 4:53 PM EDT
Izotropic Unveils Izoview Commercial Prototype, Files New Patents
Vancouver, British Columbia--(Newsfile Corp. - May 10, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, is pleased to unveil the commercial prototype device design that will be used in forthcoming clinical studies for market authorization in the U.S.
2022-05-10 8:00 AM EDT
Izotropic Corporation Announces Closing of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - April 4, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, is pleased to announce, further to its news release on March 30, 2022, that it has completed a non-brokered private placement (the "Offering") of unsecured promissory notes (each,...
2022-04-04 8:00 AM EDT
Autorität für Brust-CT und Leiterin klinischer Studien tritt Izotropic bei
Vancouver, British Columbia--(Newsfile Corp. - Dienstag, 15. März 2022) - Die Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Unternehmen, das eine spezielle Brust-CT-Bildgebungsplattform IzoView (Computertomographie) für die genauere Brustkrebserkennung und -diagnose vermarktet, freut sich, die Ernennung von Dr. Shadi Aminololama-Shakeri, MD, FSBI, in seinen Beirat und sein Kommerzialisierungsteam als klinische Beraterin bekanntzugeben....
2022-03-15 6:49 PM EDT
Breast CT Authority and Head of Clinical Trials Joins Izotropic
Vancouver, British Columbia--(Newsfile Corp. - March 14, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, is pleased to announce the addition of Dr. Shadi Aminololama- Shakeri, MD, FSBI to its advisory board and commercialization team as a clinical consultant. Dr. Shakeri is the Chief...
2022-03-14 8:00 AM EDT
Izotropic baut eine Technologie- und Entwicklungsanlage in den USA auf
Vancouver, British Columbia--(Newsfile Corp. - Dienstag, 8. März 2022) - Die Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Unternehmen, das eine spezielle Brust-CT (Computertomographie) Bildgebungsplattform, IzoView, für die genauere Erkennung und Diagnose von Brustkrebs vermarktet, gibt bekannt, dass es seine medizinische Gerätetechnik und Produktentwicklung in seine interne Einrichtung in Sacramento, CA, verlegen wird. Der Schritt kommt...
2022-03-08 12:51 PM EST
Izotropic Establishing Engineering and Development Facility in the USA
Vancouver, British Columbia--(Newsfile Corp. - March 7, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers announces it is bringing its medical device engineering and product development to its in-house facility located in Sacramento, CA. The move comes at a critical time as Izotropic is...
2022-03-07 8:00 AM EST